Home AEC Lincoln Property Company Buys Life Science Development Site in Seattle for $42MM
AECCommercialFinanceIndustry NewsLife Science

Lincoln Property Company Buys Life Science Development Site in Seattle for $42MM

Share
DivcoWest Pacific Northwest Dyal Capital Blue Owl Capital
Photo by Nitish Meena on Unsplash
Share

By Jon Peterson Opportunities for the life science sector across the greater Puget Sound region are capturing interest from national investment companies. Lincoln Property Company, through its Portland/Seattle office, has closed on the purchase of a life science development site in Seattle located at 222 Fifth Avenue North. The purchase price was $42 million, according to public records. […]

Thank you for your interest in The Registry. If you'd like to read further, you must Subscribe or Log In below to read the rest of this content.

Share

2026 Pacific Northwest CRE Rising Stars

PNW CRE Rising Stars

Featured Posts


Recent Posts

Related Articles

BRIDGE Housing Wins AA Rating from S&P, Setting the High-Water Mark for Nonprofit Housing Developers

S&P Global Ratings lifted BRIDGE Housing Corp.'s issuer credit rating and the...

Eastside’s 14.7MM SQFT Office Pipeline Still Has Zero Pre-Leasing as Supply Freeze Props Up Bellevue Recovery

Broderick Group's third-quarter report still counts roughly 14.7 million square feet of...

Hudson-Led Venture Lands 20-Year Deal for 31,000 SQFT Duty-Free Expansion at Seattle-Tacoma Airport

The Port of Seattle has handed a joint venture of Avolta-owned Hudson...